Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Myelodysplastic-Myeloproliferative Diseases × pembrolizumab × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 226 Melanoma 121 Squamous Cell Carcinoma of Head and Neck 119 Parkinson Disease 4, Autosomal Dominant Lewy Body 104 Neoplasm Metastasis 87 Lung Neoplasms 84 Triple Negative Breast Neoplasms 83 Neoplasms 76 Breast Neoplasms 70 Carcinoma, Renal Cell 62 Colorectal Neoplasms 60 Head and Neck Neoplasms 49 Stomach Neoplasms 44 Urinary Bladder Neoplasms 40 Ovarian Neoplasms 40 Carcinoma, Transitional Cell 38 Endometrial Neoplasms 37 Pancreatic Neoplasms 34 Carcinoma, Hepatocellular 33 Uterine Cervical Neoplasms 31 Prostatic Neoplasms 26 Esophageal Neoplasms 25 Glioblastoma 23 Carcinoma, Squamous Cell 23 Carcinoma 22 Brain Neoplasms 20 Skin Neoplasms 19 Sarcoma 19 Recurrence 19 Hodgkin Disease 19

Interventions

Specimen Handling 7 Biopsy 6 Cyclophosphamide 5 ruxolitinib 4 Mycophenolic Acid 4 Busulfan 4 fludarabine phosphate 3 fludarabine 3 Whole-Body Irradiation 3 Tacrolimus 3 Melphalan 3 Injections 3 Decitabine 3 Cyclosporine 3 Azacitidine 3 venetoclax 2 decitabine and cedazuridine drug combination 2 Sirolimus 2 Methotrexate 2 Granulocyte Colony-Stimulating Factor 2 veliparib 1 tocilizumab 1 tagraxofusp 1 posaconazole 1 peginterferon alfa-2b 1 onvansertib 1 merphos 1 iadademstat 1 gilteritinib 1 fedratinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡